Given the potentially significant role of intestinal AMPK activation in PCOS treatment with metformin, this study aims to further explore the mechanisms of intestinal AMPK activation in metabolic regulation and its impact on treatment strategies. Here, PRKAA1 is linked to polycystic ovary syndrome.